Current Research Announcements

Below are current research studies being conducted in the field of perinatal mental health. The PSI Research Committee has reviewed study summaries and ethical procedures, and have approved these studies for inclusion on our website. 

  • If you have a reseach project relating to pregnancy, postpartum, or post-loss mental health, you can submit a request for us to include a summary of your project and a call for enrollment.
  • Write to us with questions at psioffice@postpartum.net
  • Enroll in study? Please visit the link listed below.

National Pregnancy Registry for Atypical Antipsychotics

The National Pregnancy Registry for Atypical Antipsychotics is dedicated to evaluating the safety of atypical antipsychotic medications that may be taken by women during pregnancy to treat a wide range of mood, anxiety, or psychiatric disorders. The goal of this Registry is to gather information on the safety of these medications during pregnancy, as current data is limited. All pregnant women ages 18-45 are eligible to enroll in the registry. The Registry website houses information for both participants and clinicians, including enrollment guidelines, resources on atypical antipsychotics, and notes on some of preliminary research findings. Please visit the website HERE for more information. 

UNC Department of Psychiatry Research -- Call for Participants

Have you given birth recently and are you depressed?


Doctors at UNC Chapel Hill are seeking women for a medical research study of an investigational drug for Postpartum Depression.


 

You may be eligible if you are:
  • Female between the ages of 18 and 45
  • Gave birth 2 weeks to 6 months ago
  • Currently experiencing depression after giving birth

This study requires a 4-day in-patient stay on the Perinatal Psychiatry Unit at UNC hospital. Participants will have their in-patient costs paid for by the research study and will receive up to $1300 for participation.

For additional information, please call Katie at 919-445-0218.
UNC School of Medicine



This study was approved 2/23/15 by the Committee on the Protection of the Rights of Human Subjects Biomedical Institutional Review Board, IRB# 14-0516, and sponsored by the UNC Department of Psychiatry.

Lamotrigine in Pregnant and Postpartum Women

Are you or someone you know taking Lamotrigine (Lamictal) for Bipolar Disorder and Planning to Have a Baby?

The Asher Center for the Study and Treatment of Depressive Disorders at Northwestern University
is seeking women to participate in a study investigating changes in the concentration of lamotrigine during pregnancy in women with mood disorders.

Study Title: Pharmacokinetics of Lamotrigine in Pregnant and Postpartum Women with Bipolar Disorder

Background: Lamictal (lamotrigine) is FDA approved and commonly used to treat Bipolar Disorder. Because Bipolar Disorder frequently affects women during their reproductive years, it is important for us to understand how the dose of Lamictal should be modified for women who are pregnant. By participating in this study, you can help optimize the quality of care for women with Bipolar Disorder.

Goal: To understand the need for changes in dosage level of Lamictal for pregnant women with a history of Bipolar Disorder

Eligibility: Women ages 18-45; Diagnosis of Bipolar Disorder or Mood Disorder NOS; Planning to become pregnant, or in the first or second trimester of pregnancy; Taking daily dose of Lamictal (lamotrigine) for mood symptom management

What you will do: At your initial visit, you will complete a full psychiatric evaluation with Dr. Clark at no cost to you. At each subsequent visit, you will stay overnight in the clinical research unit and complete assessments to monitor your mood, as well as blood draws to monitor your lamotrigine levels.

Compensation: Reimbursement for on-site parking; Financial compensation for every study visit you complete; Medical consultation with Dr. Crystal Clark about the best treatment for you throughout pregnancy; Gifts for you and your baby; Careful monitoring of your mood symptoms throughout pregnancy at no cost to you

IRB Project Number: STU #00079810
Principal Investigator: Crystal T. Clark, MD, MSc

For more information, contact:

Study coordinator Stephanie Schuette, at 312-695-6010. stephanie.schuette@northwestern.edu

Below are current research studies being conducted in the field of perinatal mental health. The PSI Research Committee has reviewed study summaries and ethical procedures, and have approved these studies for inclusion on our website. 

  • If you have a reseach project relating to pregnancy, postpartum, or post-loss mental health, you can submit a request for us to include a summary of your project and a call for enrollment.
  • Write to us with questions at psioffice@postpartum.net
  • Enroll in study? Please visit the link listed below.

National Pregnancy Registry for Atypical Antipsychotics

The National Pregnancy Registry for Atypical Antipsychotics is dedicated to evaluating the safety of atypical antipsychotic medications that may be taken by women during pregnancy to treat a wide range of mood, anxiety, or psychiatric disorders. The goal of this Registry is to gather information on the safety of these medications during pregnancy, as current data is limited. All pregnant women ages 18-45 are eligible to enroll in the registry. The Registry website houses information for both participants and clinicians, including enrollment guidelines, resources on atypical antipsychotics, and notes on some of preliminary research findings. Please visit the website HERE for more information. 

UNC Department of Psychiatry Research -- Call for Participants

Have you given birth recently and are you depressed?


Doctors at UNC Chapel Hill are seeking women for a medical research study of an investigational drug for Postpartum Depression.


 

You may be eligible if you are:
  • Female between the ages of 18 and 45
  • Gave birth 2 weeks to 6 months ago
  • Currently experiencing depression after giving birth

This study requires a 4-day in-patient stay on the Perinatal Psychiatry Unit at UNC hospital. Participants will have their in-patient costs paid for by the research study and will receive up to $1300 for participation.

For additional information, please call Katie at 919-445-0218.
UNC School of Medicine



This study was approved 2/23/15 by the Committee on the Protection of the Rights of Human Subjects Biomedical Institutional Review Board, IRB# 14-0516, and sponsored by the UNC Department of Psychiatry.

Lamotrigine in Pregnant and Postpartum Women

Are you or someone you know taking Lamotrigine (Lamictal) for Bipolar Disorder and Planning to Have a Baby?

The Asher Center for the Study and Treatment of Depressive Disorders at Northwestern University
is seeking women to participate in a study investigating changes in the concentration of lamotrigine during pregnancy in women with mood disorders.

Study Title: Pharmacokinetics of Lamotrigine in Pregnant and Postpartum Women with Bipolar Disorder

Background: Lamictal (lamotrigine) is FDA approved and commonly used to treat Bipolar Disorder. Because Bipolar Disorder frequently affects women during their reproductive years, it is important for us to understand how the dose of Lamictal should be modified for women who are pregnant. By participating in this study, you can help optimize the quality of care for women with Bipolar Disorder.

Goal: To understand the need for changes in dosage level of Lamictal for pregnant women with a history of Bipolar Disorder

Eligibility: Women ages 18-45; Diagnosis of Bipolar Disorder or Mood Disorder NOS; Planning to become pregnant, or in the first or second trimester of pregnancy; Taking daily dose of Lamictal (lamotrigine) for mood symptom management

What you will do: At your initial visit, you will complete a full psychiatric evaluation with Dr. Clark at no cost to you. At each subsequent visit, you will stay overnight in the clinical research unit and complete assessments to monitor your mood, as well as blood draws to monitor your lamotrigine levels.

Compensation: Reimbursement for on-site parking; Financial compensation for every study visit you complete; Medical consultation with Dr. Crystal Clark about the best treatment for you throughout pregnancy; Gifts for you and your baby; Careful monitoring of your mood symptoms throughout pregnancy at no cost to you

IRB Project Number: STU #00079810
Principal Investigator: Crystal T. Clark, MD, MSc

For more information, contact:

Study coordinator Stephanie Schuette, at 312-695-6010. stephanie.schuette@northwestern.edu

image

donate now
resources for fathers  
find local helpget the facts

donate now
resources for fathers  
find local helpget the facts